Phagenesis Ltd, announced that the U.S. Food and Drug Administration has granted a De Novo request for the Phagenyx® Neurostimulation System, a first-of-its-kind therapy that uses pharyngeal electrical stimulation to restore swallowing control in patients with severe dysphagia post stroke.
October 10, 2022
· 3 min read
